DRKS00015267
Completed
Not Applicable
ong term, prospective, observational cohort study evaluating the safety profile in patients with highly active relapsing multiple sclerosis (RMS) newly started on oral cladribine - CLARIO
ConditionsG35.9
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- G35.9
- Sponsor
- Merck KGaA
- Enrollment
- 1115
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly initiating oral cladribine or fingolimod according to local label for MS, after the date of oral cladribine launch in the relevant country.
- •\- Written informed consent is obtained:
- •\- at the date of oral cladribine or fingolimod treatment initiation or, at the latest, 24 weeks after oral cladribine or fingolimod treatment initiation in all countries for which primary data is used.
- •\- in those countries where secondary data collection is used and require an informed consent.
Exclusion Criteria
- •\- Received fingolimod prior to initiating oral cladribine;
- •\- Received oral cladribine prior to initiating fingolimod.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
ong term prospective observational cohort study on the safety and efficacy of abatacept subcutaneus in the daily clinical practice of rheumatoid arthritisInflammatory rheumatic disease10023213NL-OMON39013Jan van Breemen Instituut100
Recruiting
Phase 4
ong term prospective observational cohort study of the safety and efficacy of golimumab in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36406Jan van Breemen Instituut200
Recruiting
Phase 4
ong term prospective observational cohort study of the safety and efficacy of certolizumab pegol in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36770Jan van Breemen Instituut200
Recruiting
Not Applicable
A longitudinal prospective, observational, cohort study in lactating mothers and their newborns to further unravel the complexity of human milkNL-OMON53220utricia Research120
Not yet recruiting
Not Applicable
Comparison of suspected or negative cases with confirmed cases of COVID-19 at Max HospitalCTRI/2020/04/024772Max Healthcare A Unit of Devki Devi Foundation